Han-Ting Wang is a Supervising Producer at CNBC Digital and oversees CNBC.com's original video productions and programming strategy. Previously he was the Senior Producer and editorial lead of Closing Bell with Maria Bartiromo & Bill Griffeth on CNBC TV.
Prior to joining CNBC, Han-Ting was a Supervising Producer at Bloomberg Television.
Han-Ting holds a Master's degree in Broadcast Journalism from New York University and a Bachelor's degree from Georgetown University's College of Arts & Sciences.
Follow Han-Ting on Twitter: @tingwang8
Anything can happen between the bells of the trading day. But what happens during the last hour could be what matters most. CNBC's "Closing Bell" guides you through the most important hour of the trading day. The show takes a close-up look at how the markets are moving, what's driving them and how investors are reacting.
Live coverage includes reports from the Chicago Board of Trade, New York Mercantile Exchange, NASDAQ and the NYSE. Analysts, money managers and CEOs explain their strategies, share opinions, and provide an inside perspective on breaking news stories.
In addition, "Closing Bell" provides instant analysis of corporate profit reports, as soon as they break, during the quarterly earning seasons. Features include interviews with entrepreneurs, plus an inside-look at how executives and high-net-worth individuals spend their time and money.
Donald Trump protesters broke through a barricade in California; a new study finds a link between Rosacea and Alzheimer's.
Subir Grewak, Washington Square Capital management, explains why he supports Bernie Sanders.
CNBC's Eamon Javers reports the details from the Treasury foreign trade report.
This is how Oaktree's Howard Marks avoids getting trapped by the short-term emotions of the market.
Some big-name investors are betting they'll get premiums from troubled Valeant Pharmaceuticals.
CNBC's Kelly Evans gets a closer look at Square's payment system with Square's hardware lead, Jesse Dorogusker.
Martin Shroeter, IBM Senior vice president & CFO, discusses his company's quarterly results and new acquisitions.
Bill Miller said the troubled pharmaceutical company should be worth about double its current trading price.
Low commodity prices and regulatory action have crushed fossil fuel companies' ability to operate, a former CFTC head said.